[Importance of exit site care as peritonitis prophylaxis: experience in our centre].
Conde Rivera
O
O
Santos Nores
J
J
Borrajo Prol
M
M
Pérez Melón
C
C
D000287:Administration, Topical; D019072:Antibiotic Prophylaxis; D002177:Candidiasis / Q000209:etiology / Q000517:prevention & control; D055499:Catheter-Related Infections / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D002408:Catheters, Indwelling; D020878:Device Removal; D005839:Gentamicins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D016905:Gram-Negative Bacterial Infections / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D010530:Peritoneal Dialysis / Q000009:adverse effects* / Q000295:instrumentation; D010538:Peritonitis / Q000453:epidemiology / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control*; D013203:Staphylococcal Infections / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control
D005839:Gentamicins